Lipoprotein peroxidation and mobility limitation: Results from the health, aging, and body composition study

Archives of Internal Medicine

Volumn 165, Issue 18, 2005, Pages 2148-2154

  Cesari, Matteo ^a,b   Kritchevsky, Stephen B ^b   Nicklas, Barbara J ^b   Penninx, Brenda W H J ^c   Holvoet, Paul ^d   Koh Banerjee, Pauline ^e   Cummings, Steven R ^f   Harris, Tamara B ^g   Newman, Anne B ^h   Pahor, Marco ^a,b  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

^c VU UNIVERSITY AMSTERDAM   (Netherlands)

^d UNIVERSITY OF LEUVEN   (Belgium)

^e UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g NATIONAL INSTITUTE ON AGING   (United States)

^h UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OXIDIZED LOW DENSITY LIPOPROTEIN;

AGED; AGING; ARTICLE; BODY COMPOSITION; BODY MASS; CLIMBING; CONFIDENCE INTERVAL; COVARIANCE; DEMOGRAPHY; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; LIPID PEROXIDATION; MALE; MOTOR PERFORMANCE; OXIDATIVE STRESS; PHYSICAL ACTIVITY; PHYSICAL DISABILITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REST; SMOKING; STATISTICAL SIGNIFICANCE; TASK PERFORMANCE; WALKING;

AGED; AGING; BIOLOGICAL MARKERS; BODY COMPOSITION; CHOLESTEROL, LDL; COHORT STUDIES; FEMALE; GERIATRIC ASSESSMENT; HEALTH STATUS; HUMANS; LIPID PEROXIDATION; LIPOPROTEINS, LDL; LOCOMOTION; MALE; PROSPECTIVE STUDIES; RANGE OF MOTION, ARTICULAR;

EID: 26444574826     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinte.165.18.2148     Document Type: Article

References (52)

1. Harman D. Aging: a theory based on free radical and radiation chemistry. J Gerontol. 1956;2:298-300.
2. Finkel T, Holbrook NJ. Oxidants, oxidative stress and the biology of ageing. Nature. 2000;408:239-247.
3. Halliwell B, Gutteridge JMC. Free Radicals in Biology and Medicine. 3rd ed. Oxford, England: Oxford University Press; 1999.
4. Aust SD, Morehouse LA, Thomas CE. Role of metals in oxygen radical reactions. J Free Radic Biol Med. 1985;1:3-25.
5. Sevanian A, Hochstein P. Mechanisms and consequences of lipid peroxidation in biological systems. Annu Rev Nutr. 1985;5:365-375.
6. Franceschi C, Bonafe M, Valensin S, et al. Inflamm-aging: an evolutionary perspective on immunosenescence. Ann N Y Acad Sci. 2000;908:244-254.
7. Davi G, Falco A, Patrono C. Determinants of F2-isoprostane biosynthesis and inhibition in man. Chem Phys Lipids. 2004;128:149-163.
8. Holvoet P, Harris TB, Tracy RP, et al. Association of high coronary heart disease risk status with circulating oxidized LDL in the well-functioning elderly: findings from the Health, Aging, and Body Composition Study. Arterioscler Thromb Vasc Biol. 2003;23:1444-1448.
9. Liu ML, Ylitalo K, Salonen R, Salonen JT, Taskinen MR. Circulating oxidized lowdensity lipoprotein and its association with carotid intima-media thickness in asymptomatic members of familial combined hyperlipidemia families. Arterioscler Thromb Vasc Biol. 2004;24:1492-1497.
10. Rosenson RS. Statins in atherosclerosis: lipid-lowering agents with antioxidant capabilities. Atherosclerosis. 2004;173:1-12.
11. Ferrucci L, Harris TB, Guralnik JM, et al. Serum IL-6 level and the development of disability in older persons. J Am Geriatr Soc. 1999;47:639-646.
12. Fried LP, Guralnik JM. Disability in older adults: evidence regarding significance, etiology, and risk. J Am Geriatr Soc. 1997;45:92-100.
13. Melzer D, Lan TY, Guralnik JM. The predictive validity for mortality of the index of mobility-related limitation: results from the EPESE study. Age Ageing. 2003;32:619-625.
14. Guralnik JM, Fried LP, Salive ME. Disability as a public health outcome in the aging population, I: demographic characteristics and chronic conditions. Annu Rev Public Health. 1996;17:25-46.
15. Schneider EL, Guralnik JM. The aging of America: impact on health care costs. JAMA. 1990;263:2335-2340.
16. Simonsick EM, Newman AB, Nevitt MC, et al. Measuring higher level physical function in well-functioning older adults: expanding familiar approaches in the Health ABC study. J Gerontol A Biol Sci Med Sci. 2001;56:M644-M649.
17. Holvoet P, Kritchevsky SB, Tracy RP, et al. The metabolic syndrome, circulating oxidized LDL, and risk of myocardial infarction in well-functioning elderly people in the Health, Aging, and Body Composition cohort. Diabetes. 2004;53:1068-1073.
18. Fried LP, Borhani NO, Enright P, et al. The Cardiovascular Health Study: design and rationale. Ann Epidemiol. 1991;1:263-276.
19. Lee IM, Paffenbarger RS Jr, Hsieh CC. Time-trends in physical activity among college alumni. Am J Epidemiol. 1992;135:915-925.
20. Albanes D, Conway JM, Taylor PR, Moe PW, Judd J. Validation and comparison of eight physical activity questionnaires. Epidemiology. 1990;1:65-71.
21. Washburn RA, Smith KW, Goldfield SRW, McKinlay JB. Reliability and physiologic correlates of the Harvard Alumni Activity Survey in a general population. J Clin Epidemiol. 1991;44:1319-1326.
22. Ainsworth BE, Leon AS, Richardson MT, Jacons DR, Paffenberger RS Jr. Accuracy of the College Alumnus Physical Activity Questionnaire. J Clin Epidemiol. 1993;46:1403-1411.
23. Friedewald W, Levy R, Fredrickson D. Estimation of the concentration of lowdensity-lipoprotein cholesterol in plasma without the use of the ultracentrifuge. Clin Chem. 1972;18:499-502.
24. Leng S, Chaves P, Koenig K, Walston J. Serum interleukin 6 and hemoglobin as physiological correlates in the geriatric syndrome of frailty: a pilot study. J Am Geriatr Soc. 2002;50:1268-1271.
25. Cohen HJ, Pieper CF, Harris TB, Rao KM, Currie MS. The association of plasma IL-6 levels with functional disability in community-dwelling elderly. J Gerontol A Biol Sci Med Sci. 1997;52:M201-M208.
26. Kuller LH. Serum levels of IL-6 and development of disability in older persons. J Am Geriatr Soc. 1999;47:755-756.
27. Rao KM, Pieper CS, Currie MS, Cohen HJ. Variability of plasma IL-6 and crosslinked fibrin dimers over time in community dwelling elderly subjects. Am J Clin Pathol. 1994;102:802-805.
28. Newman AB, Arnold AM, Naydeck BL, et al. "Successful aging": effect of subclinical cardiovascular disease. Arch Intern Med. 2003;163:2315-2322.
29. Davi G, Chiarelli F, Santilli F, et al. Enhanced lipid peroxidation and platelet activation in the early phase of type 1 diabetes mellitus: role of interleukin 6 and disease duration. Circulation. 2003;107:3199-3203.
30. Fiebich BL, Hull M, Lieb K, Gyufko K, Berger M, Bauer J. Prostaglandin E2 induces interleukin 6 synthesis in human astrocytoma cells. J Neurochem. 1997;68:704-709.
31. Cohen HJ, Harris T, Pieper CF. Coagulation and activation of inflammatory pathways in the development of functional decline and mortality in the elderly. Am J Med. 2003;114:180-187.
32. Schols AM, Buurman WA, Staal van den Brekel AJ, Dentener MA, Wouters EF. Evidence for a relation between metabolic derangements and increased levels of inflammatory mediators in subgroup of patients with chronic obstructive pulmonary disease. Thorax. 1996;51:819-824.
33. Anker SD, Ponikowski PP, Clark AL, et al. Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure. Eur Heart J. 1999;20:683-693.
34. Visser M, Pahor M, Taaffe DR, et al. Relationship of interleukin 6 and tumor necrosis factor-alpha with muscle mass and muscle strength in elderly men and women: the Health ABC study. J Gerontol A Biol Sci Med Sci. 2002;57:M326-M332.
35. Haslett P, Hempstead M, Seidman C, et al. The metabolic and immunologic effects of short-term thalidomide treatment of patients infected with the human immunodeficiency virus. AIDS Res Hum Retroviruses. 1997;13:1047-1054.
36. Garcia-Martinez C, Lopez-Soriano FJ, Argiles JM. Acute treatment with tumor necrosis factor-alpha induces changes in protein metabolism in rat skeletal muscle. Mol Cell Biochem. 1993;125:11-18.
37. Hoshino E, Pichard C, Greenwood CE, et al. Body composition and metabolic rate in rat during a continuous infusion of cachectin. Am J Physiol. 1991;260:E27-E36.
38. Charters Y, Grimble RF. Effects of recombinant human tumor necrosis factor alpha on protein synthesis in liver, skeletal muscle and skin of rats. Biochem J. 1989;258:493-497.
39. Davi G, Guagnano MT, Ciabattoni G, et al. Platelet activation in obese women: role of inflammation and oxidative stress. JAMA. 2002;288:2008-2014.
40. Fried LP, Tangen CM, Walston J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56:M146-M156.
41. Gopaul NK, Nourooz-Zadeh J, Mallet AI, Anggard EE. Formation of PGF2-isoprostanes during the oxidative modification of low density lipoprotein. Biochem Biophys Res Commun. 1994;200:338-343.
42. Moore KP, Darley-Usmar V, Morrow J, Roberts LJ II. Formation of F2-isoprostanes during oxidation of human low-density lipoprotein and plasma by peroxynitrite. Circ Res. 1995;77:335-341.
43. Hauer K, Hildebrandt W, Sehl Y, Edler L, Oster P, Dröge W. Improvement in muscular performance and decrease in tumor necrosis factor level in old age after antioxidant treatment. J Mol Med. 2003;81:118-125.
44. Upritchard JE, Schuurman CRWC, Wiersma A, et al. Spread supplemented with moderate doses of vitamin E and carotenoids reduces lipid peroxidation in healthy, nonsmoking adults. Am J Clin Nutr. 2003;78:985-992.
45. Takanami Y, Iwane H, Kawai Y, Shimomitsu T. Vitamin E supplementation and endurance exercise: are there benefits? Sports Med. 2000;29:73-83.
46. Oostenbrug GS, Mensink RP, Hardeman MR, De Vries T, Brouns F, Hornstra G. Exercise performance, red blood cell deformability, and lipid peroxidation: effects of fish oil and vitamin E. J Appl Physiol. 1997;83:746-752.
47. Clarkson PM. Antioxidants and physical performance. Crit Rev Food Sci Nutr. 1995;35:131-141.
48. Van der Beek EJ. Vitamin supplementation and physical performance. J Sports Sci. 1991;9:77-90.
49. Jackson M, Edwards RH. Free radicals and trials of antioxidant therapy in muscle disorders. Adv Exp Med Biol. 1990;264:485-491.
50. Fulle S, Protasi F, Di Tano G, et al. The contribution of reactive oxygen species to sarcopenia and muscle ageing. Exp Gerontol. 2004;39:17-24.
51. Wang JS, Lin CC, Chen JK, Wong MK. Role of chronic exercise in decreasing oxidized LDL-potentiated platelet activation by enhancing platelet-derived NO release and bioactivity in rats. Life Sci. 2000;66:1937-1948.
52. Messier SP, Loeser RF, Miller GD, et al. Exercise and diet weight loss in overweight and obese older adults with knee osteoarthritis: the Arthritis, Diet, and Activity Promotion Trial. Arthritis Rheum. 2004;50:1501-1510.